Roche Achieves Strong Sales Growth Despite COVID-19 Product Demand Decline
Swiss pharmaceutical giant Roche has demonstrated impressive performance in the first nine months of 2023, achieving a 1% increase in group sales when measured...
Health Technology Council to Evaluate Transcranial Magnetic Stimulation for Treatment-Resistant Depression
In a significant development for the field of mental health, the Health Technology Council has initiated an evaluation process to determine the viability of...
China Approves CANbridge’s NDA for CAN108 to Treat Cholestatic Pruritus in PFIC
The National Drug Administration (NDA) has received a submission based on data from the randomized Phase III MARCH PFIC study of LIVMARLI. The study...
ViiV Healthcare Showcases 23 Abstracts Highlighting Innovative HIV Care and Prevention at EACS 2023
ViiV Healthcare, a global leader in HIV care and research, will present significant research findings at the 19th Annual European AIDS Conference (EACS 2023)...
China Approves Soliris for Treating Neuromyelitis Optica Spectrum Disorder (NMOSD) in Adults
Soliris, an innovative treatment, has gained approval in China for adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive...
Public Acute Hospitals’ Monitoring Inspection Reports Released on October 17, 2023
The Health Information and Quality Authority (HIQA) released five inspection reports assessing compliance with the National Standards for Safer Better Healthcare. These inspections were...
Global Expansion on the Horizon for Medical Drone Deliveries
The use of drones for deliveries is often associated with retail, aiming to expedite the delivery of consumer goods. However, medical drone delivery, an...
Italy Set to Roll Out Nationwide Child Screening Program for Type 1 Diabetes and Celiac Disease in 2024
The Italian Ministry of Health has unveiled plans to launch a national screening initiative for type 1 diabetes and celiac disease in children aged...
Disability Services Update: Announcement Released on October 18, 2023
The Health Information and Quality Authority (HIQA) has released 29 inspection reports today, covering designated centers for individuals with disabilities in Ireland. These inspections...
Simultaneous NICE Recommendation and UK Approval for Pioneering Lymphoma Treatment
The National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for glofitamab as a new treatment option for adults suffering...
Roche’s IL-6 Immunoassay Granted First Approval for Diagnosing Neonatal Sepsis
Roche's Elecsys IL-6 immunoassay has achieved a significant milestone by becoming the first IL-6 test with a certified claim for diagnosing neonatal sepsis in...
Alecensa by Roche Slashes Disease Recurrence Risk by Unprecedented 76% in ALK-Positive Early-Stage Lung Cancer
Roche's Alecensa demonstrates a remarkable 76% reduction in the risk of disease recurrence or death in early-stage anaplastic lymphoma kinase (ALK)-positive non-small cell lung...
Biopharma Sector Faces Low Success Rate in Mergers and Acquisitions Earn-Outs
Commercial milestones in the biopharma sector often make up to 40% of the earn-out potential in mergers and acquisitions. Yet, a report from SRS...
Healthcare Shifts Amid Post-Pandemic Adjustments and Declining COVID-19 Cases
The healthcare industry is transforming the rates of COVID-19 decreased and the need for vaccines and related products has decreased. This change is deeply...
MSD Issues Caution to UK as $1.3 Billion Research Facility Project Looms
Pharmaceutical giant MSD (known as Merck & Co in North America) has expressed concerns about the future of its $1.32 billion research facility in...
